Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
20 Dec 2025 Job Information Organisation/Company University of Basel Research Field Biological sciences » Biology Biological sciences » Other Engineering » Other Medical sciences » Other Technology
-
for Metabolic Imaging (W2) This professorship will be based at the Department of Diagnostic and Interventional Radiology, which isequipped with state-of-the-art medical imaging technology (including Fibroscan
-
biotechnology. These research fields include (1) analyses of metabolism by information engineering, (2) measurement of biosystems by using mass spectrometry, and (3) developments of new information technologies
-
systems to drive sustainable bioconversion processes. Apply metabolic engineering approaches to enhance microbial conversion efficiency. Perform experiments to assess the performance and stability
-
the laboratory of Dr. Myles Wolf focuses on the investigation of mineral metabolism and tissue-specific vitamin D metabolism in chronic kidney disease. Normal calcium and phosphate homeostasis is essential
-
or hardware acceleration for omics technologies - Systems, molecular, or metabolic engineering - Translational and precision medicine Projects will be tailored to each scholar’s background, interests, and
-
major initiative at the interface between cancer, immunity, and metabolism (Ludwig Princeton Branch). We welcome applications from candidates using biological, chemical, physical, engineering, and/or
-
Job Description The Division of Metabolism, Endocrinology and Nutrition (MET) has an outstanding opportunity for a Research Scientist/Engineer Senior to join their team. The Division of Metabolism
-
, scientists with expertise in metabolic engineering, enzyme engineering, computational modelling, and process optimization will work together. By combining microbial strains with synthetic metabolism with
-
: (1) the chemical regulation of nuclear xenobiotic receptors, (2) the mechanism of selective modulation of highly homologous drug-metabolizing enzymes. We are taking a hypothesis-driven and technology